ENTOD Pharmaceuticals

The initiative aims to expand preventive education, screenings, and community engagement across 450 districts in India

New formulation targets eye health by restoring ocular and gut microbiota balance, supporting long-term wellness

Masurkar has pledged to help mobilise collaborative initiatives that promote research-led development, facilitate strategic…

The formulation, approved following Phase 3 trials in India, becomes the first globally authorised treatment strength for slowing…

As CFO, he will oversee financial strategy, budgeting, and risk management, helping Entod strengthen its financial position

ENTOD’s current research pipeline aims to address critical healthcare challenges, including myopia, digital eye strain, and…

Former OPPI Director joins ENTOD’s board, bringing expertise in pharma policy and innovation

EyeBS replaces traditional detergent-based preservatives with ionic buffer blend for improved ocular safety

Industry leaders highlight priorities ahead of Union Budget, calling for R&D incentives and reduced GST to propel growth and…

Clinical trials have demonstrated PresVu's efficacy in enhancing close-up vision within minutes of application